About
iDerm Pharma is a biotechnology company developing a first-in-class oral small molecule therapy targeting autoimmune inflammatory skin diseases such as psoriasis by modulating a novel local inflammatory pathway to provide safe and effective treatment.
Explore iDerm Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.